0001567619-21-006502.txt : 20210317 0001567619-21-006502.hdr.sgml : 20210317 20210317164746 ACCESSION NUMBER: 0001567619-21-006502 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210316 FILED AS OF DATE: 20210317 DATE AS OF CHANGE: 20210317 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kiraly Thomas E CENTRAL INDEX KEY: 0001623986 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10670 FILM NUMBER: 21751146 MAIL ADDRESS: STREET 1: 10910 DOMAIN DRIVE, SUITE 300 CITY: AUSTIN STATE: TX ZIP: 78758 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HANGER, INC. CENTRAL INDEX KEY: 0000722723 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093] IRS NUMBER: 840904275 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10910 DOMAIN DRIVE STREET 2: SUITE 300 CITY: AUSTIN STATE: TX ZIP: 78758 BUSINESS PHONE: 512-777-3800 MAIL ADDRESS: STREET 1: 10910 DOMAIN DRIVE STREET 2: SUITE 300 CITY: AUSTIN STATE: TX ZIP: 78758 FORMER COMPANY: FORMER CONFORMED NAME: HANGER ORTHOPEDIC GROUP INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: SEQUEL CORP DATE OF NAME CHANGE: 19890814 FORMER COMPANY: FORMER CONFORMED NAME: CELLTECH COMMUNICATIONS INC DATE OF NAME CHANGE: 19860304 4 1 doc1.xml FORM 4 X0306 4 2021-03-16 0 0000722723 HANGER, INC. HNGR 0001623986 Kiraly Thomas E 10910 DOMAIN DRIVE SUITE 300 AUSTIN TX 78758 0 1 0 0 EVP & Chief Financial Officer Common Stock 2021-03-16 4 S 0 8750 23.9293 D 268325 D Stock Options (right to buy) 12.77 2027-05-19 Common Stock 62778 31389 D The sale by Mr. Kiraly was effected automatically upon the satisfaction of certain timing, trading price and other conditions under a trading plan designed to comply with Rule 10b5-1 of the Securities Exchange Act of 1934. Mr. Kiraly entered into this trading plan on December 4, 2020 and additional periodic sales may occur under this plan through the end of 2021 if the conditions of the plan are met. These shares were sold at a range of sale prices from $23.62 to $24.31. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Includes (i) unvested restricted shares totaling 17,435 shares of stock from an initial grant of 17,435 shares of restricted stock which begins to vest on March 8, 2022 (ii) unvested restricted shares totaling 13,094 shares of stock from an initial grant of 14,523 shares of restricted stock which begins to vest on March 9, 2021 (iii) unvested restricted shares totaling 15,404 shares of stock from an initial grant of 17,085 shares of restricted stock made on March 9, 2020; (iv) unvested restricted shares and fully vested shares totaling 12,999 shares of stock from an initial grant of 16,185 shares of restricted stock made on March 8, 2019; [continued in next footnote] (v) unvested restricted shares and fully vested shares totaling 15,407 shares of stock from an initial grant of 19,181 shares of restricted stock made on March 8, 2019; (vi) unvested restricted shares and fully vested shares totaling 13,125 shares of stock from an initial grant of 18,622 shares of restricted stock made on March 9, 2018; (vii) unvested restricted shares and fully vested shares totaling 16,903 shares of stock from an initial grant of 26,250 shares of restricted stock, the remainder of which vested on March 8, 2021; (viii) unvested restricted shares and fully vested shares totaling 16,499 shares of stock from an initial grant of 23,408 shares of restricted stock made on March 8, 2018; (ix) fully vested shares totaling 16,887 shares of stock from an initial grant of 23,844 shares of restricted stock made on March 6, 2015; [continued in next footnote] (x) unvested restricted shares and fully vested shares totaling 16,098 shares of stock from an initial grant of 25,000 shares of restricted stock made on March 8, 2017; (xi) fully vested shares totaling 3,182 shares of stock from an initial grant of 5,000 shares of restricted stock made on October 11, 2016; (xii) unvested restricted shares and fully vested shares totaling 16,886 shares of stock from an initial grant of 25,000 shares of restricted stock April 29, 2016; (xiii) fully vested shares totaling 12,037 shares of stock from an initial grant of 15,896 shares of restricted stock made on March 6, 2015 and (xiv) fully vested shares totaling 38,075 shares of stock from an initial grant of 49,660 shares of restricted stock made on October 1, 2014. Except as otherwise noted, all remaining unvested restricted shares will continue to vest at a rate of 25% per year of the original grant amount on the anniversary date of the grant. Stock options were granted under the Company's Special Equity Plan and vest 1/3 on each of May 19, 2018, 2019 and 2020. Jessica Lochmann Allen, Attorney-in-Fact for Thomas E. Kiraly 2021-03-17